ABSTRACT

Pharmacovigilance refers to medical pharmacology in which adverse effects, especially longterm and short-term adverse drug reactions are detected, interpreted and mitigated. Countries around the world concentrate on developing robust pharmacovigilance programmes. At present there are no approvedCOVID-19 treatments based on extensive evidence from clinical trials and thus infection prevention, control measures, and supporting treatment are involved. While most developed nations have well-organized pharmacovigilance programmes, in developing countries there is still a lack of basic infrastructure to enforce them. The Indian pharmaceutical surveillance system is an important clinical research centre for the medical and pharmaceutical industries. This study is an attempt to emphasis on different pharmacovigilance facets during the widespread pandemic in India. Keywords: COVID-19, Pharmacovigilance
Publication date: 01/07/21

https://ijbpas.com/pdf/2021/July/MS_IJBPAS_2021_5558.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2021/10.7.5558